Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hevener, A.
Right arrow Articles by Olefsky, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hevener, A.
Right arrow Articles by Olefsky, J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:1907-1912, 2002
© 2002 by the American Diabetes Association, Inc.

Female Rats Do Not Exhibit Free Fatty Acid–Induced Insulin Resistance

Andrea Hevener1, Donna Reichart2, Andrej Janez1, and Jerrold Olefsky1,2

1 Department of Medicine, University of California, San Diego, La Jolla, California
2 Veterans Administration, San Diego Health Care System, Research Service, San Diego, California

It is well described that excessive lipid metabolism can cause insulin resistance in both animals and humans, and this has been implicated as a causative factor in the development of insulin resistance and type 2 diabetes in humans. Recently, we have shown that intravenous lipid emulsion (liposyn) infusion during a 120-min euglycemic-hyperinsulinemic clamp led to significant reductions in insulin action and fatty acid translocase (FAT/CD36) skeletal muscle protein expression. After reviewing the literature, it became evident that essentially all past studies, including our own, were conducted in male animals. Therefore, to determine whether there were sex determinants of fat-induced insulin resistance, we assessed the impact of free fatty acid (FFA) elevation on insulin action in female rats. Here, we report that a fourfold elevation in plasma FFA concentration induced a 40% reduction in the insulin-stimulated glucose disposal rate, a 30% decline in insulin-stimulated skeletal muscle insulin substrate receptor-1 (IRS-1) phosphorylation, a 48% decrease in IRS-1–associated phosphatidylinositol (PI) 3-kinase activity, and a 50% reduction in muscle FAT/CD36 protein expression in male rats. In striking contrast, we found no effect of FFA elevation to cause insulin resistance, changes in IRS-1/PI 3-kinase, or FAT/CD36 protein levels in female animals. Our findings indicate that female animals are protected from lipid-induced reductions in insulin action.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. J. Stocker, E. Wargent, J. O'Dowd, C. Cornick, J. R. Speakman, J. R. S. Arch, and M. A. Cawthorne
Prevention of diet-induced obesity and impaired glucose tolerance in rats following administration of leptin to their mothers
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1810 - R1818.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Gallou-Kabani, A. Vige, M.-S. Gross, C. Boileau, J.-P. Rabes, J. Fruchart-Najib, J.-P. Jais, and C. Junien
Resistance to high-fat diet in the female progeny of obese mice fed a control diet during the periconceptual, gestation, and lactation periods
Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1095 - E1100.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. G. Neels, M. Pandey, G. S. Hotamisligil, and F. Samad
Autoamplification of Tumor Necrosis Factor-{alpha}: A Potential Mechanism for the Maintenance of Elevated Tumor Necrosis Factor-{alpha} in Male but Not Female Obese Mice
Am. J. Pathol., February 1, 2006; 168(2): 435 - 444.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Li, P. A. Hansen, L. Xi, R. A. S. Chandraratna, and C. F. Burant
Distinct Mechanisms of Glucose Lowering by Specific Agonists for Peroxisomal Proliferator Activated Receptor {gamma} and Retinoic Acid X Receptors
J. Biol. Chem., November 18, 2005; 280(46): 38317 - 38327.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. B. Pajvani, X. Du, T. P. Combs, A. H. Berg, M. W. Rajala, T. Schulthess, J. Engel, M. Brownlee, and P. E. Scherer
Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin. IMPLICATIONS FOR METABOLIC REGULATION AND BIOACTIVITY
J. Biol. Chem., March 7, 2003; 278(11): 9073 - 9085.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.